We hypothesized that MBOAT7 may be a key link between NAFLD and coronary heart disease, and investigated both changes in MBOAT7 expression in peripheral blood leukocytes after AMI and the possible molecular mechanisms in hepatocytes. Here, MBOAT7 is linked to metabolic dysfunction-associated steatotic liver disease.